Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Zydus Cadila Group
DescriptionSmall molecule glucokinase activator
Molecular Target Glucokinase (GCK) (GK)
Mechanism of ActionGlucokinase activator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationDiabetes
Indication DetailsTreat type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today